Bayer files marketing application for larotrectinib
admin 28th August 2018 Uncategorised 0Bayer has filed a marketing application in Europe seeking approval for larotrectinib as treatment for TRK fusion cancer.
More: Bayer files marketing application for larotrectinib
Source: News